UAB, Altimmune Inc. Testing COVID-19 Vaccine

The University of Alabama at Birmingham is partnering with biopharmaceutical company Altimmune Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease. The testing at UAB will investigate immune responses to the vaccine in mice, a key step before the Maryland-based Altimmune can launch a phase 1 human safety and immunogenicity trial in…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox